trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'mbc']
2005 as a fellow at my 1st asco in orlando i saw a standing ovation to the result of adjuvant trastuzumab in her2 pos ebc. today 2022 post a horrible two years of isolation from covid i see a standing ovation to the results of t dxd in her2 low mbc. #asco2022 #asco22 
Breast cancer specialist. Shoe lover. Cupcake connoisseuse. Opinions are my own, RTs not an endorsement.